Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 11 | $51,705,533 |
| Sells | 19 | $14,112,589 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 12 Nov 2024 17:25 | MLYS | Mineralys Therapeutics Inc | RODMAN DAVID MALCOM | Chief Medical Officer | 11 Nov 2024 | Sale | 5,026 | 15.0016 | 75,398 | D |
| 08 Nov 2024 16:21 | MLYS | Mineralys Therapeutics Inc | RODMAN DAVID MALCOM | Chief Medical Officer | 06 Nov 2024 | Sale | 25,482 | 15.0328 | 383,066 | D |
| 15 Oct 2024 16:22 | MLYS | Mineralys Therapeutics Inc | LEVY ADAM SCOTT | CFO and Secretary | 11 Oct 2024 | Sale | 10,757 | 13.5729 | 146,004 | D |
| 15 Oct 2024 16:21 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 11 Oct 2024 | Sale | 15,271 | 13.518 | 206,433 | D |
| 26 Jul 2024 21:45 | MLYS | Mineralys Therapeutics Inc | SLINGSBY BRIAN TAYLOR | Director , 10% | 24 Jul 2024 | Sale | 550,000 | 13.05 | 7,177,500 | I |
| 18 Jul 2024 18:34 | MLYS | Mineralys Therapeutics Inc | RODMAN DAVID MALCOM | Chief Medical Officer | 16 Jul 2024 | Sale | 525 | 15.0011 | 7,876 | D |
| 12 Jul 2024 16:37 | MLYS | Mineralys Therapeutics Inc | LEVY ADAM SCOTT | CFO and Secretary | 11 Jul 2024 | Sale | 10,757 | 13.1444 | 141,394 | D |
| 12 Jul 2024 16:36 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 11 Jul 2024 | Sale | 15,746 | 13.3415 | 210,075 | D |
| 20 Jun 2024 17:44 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 20 Jun 2024 | Sale | 14,940 | 11.7294 | 175,237 | D |
| 20 Jun 2024 17:44 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 18 Jun 2024 | Sale | 16,607 | 11.9873 | 199,073 | D |
| 20 Jun 2024 17:44 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 17 Jun 2024 | Sale | 17,766 | 12.2544 | 217,712 | D |
| 14 Jun 2024 18:15 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 14 Jun 2024 | Sale | 16,229 | 12.5185 | 203,163 | D |
| 14 Jun 2024 18:15 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 13 Jun 2024 | Sale | 39,961 | 12.7381 | 509,027 | D |
| 14 Jun 2024 18:15 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 12 Jun 2024 | Sale | 16,607 | 12.7665 | 212,013 | D |
| 13 Jun 2024 17:33 | MLYS | Mineralys Therapeutics Inc | LEVY ADAM SCOTT | CFO and Secretary | 11 Jun 2024 | Sale | 96,815 | 12.9393 | 1,252,718 | D |
| 10 May 2024 16:17 | MLYS | Mineralys Therapeutics Inc | RODMAN DAVID MALCOM | Chief Medical Officer | 09 May 2024 | Sale | 100 | 15 | 1,500 | D |
| 14 Feb 2024 21:06 | MLYS | Mineralys Therapeutics Inc | SAMSARA BIOCAPITAL GP, LLC | 10% | 12 Feb 2024 | Purchase | 555,555 | 13.5 | 7,499,992 | I |
| 27 Nov 2023 16:01 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 22 Nov 2023 | Purchase | 4,250 | 5.9661 | 25,356 | D |
| 08 Sep 2023 08:49 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 06 Sep 2023 | Purchase | 2,250 | 12.08 | 27,180 | D |
| 21 Aug 2023 16:03 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 17 Aug 2023 | Purchase | 2,250 | 12.1 | 27,225 | D |
| 11 Aug 2023 19:11 | MLYS | Mineralys Therapeutics Inc | RODMAN DAVID MALCOM | Chief Medical Officer | 11 Aug 2023 | Sale | 76,182 | 12.81 | 975,891 | D |
| 11 Aug 2023 19:11 | MLYS | Mineralys Therapeutics Inc | RODMAN DAVID MALCOM | Chief Medical Officer | 11 Aug 2023 | Sale | 80,909 | 12.81 | 1,036,444 | D |
| 11 Aug 2023 19:11 | MLYS | Mineralys Therapeutics Inc | RODMAN DAVID MALCOM | Chief Medical Officer | 10 Aug 2023 | Sale | 74,625 | 13.16 | 982,065 | D |
| 11 Aug 2023 19:11 | MLYS | Mineralys Therapeutics Inc | CONGLETON JON | Chief Executive Officer | 11 Aug 2023 | Purchase | 2,000 | 12.89 | 25,780 | D |
| 16 Feb 2023 21:00 | MLYS | Mineralys Therapeutics Inc | HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD. | 10% | 14 Feb 2023 | Purchase | 312,500 | 16 | 5,000,000 | D |
| 16 Feb 2023 17:04 | MLYS | Mineralys Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 14 Feb 2023 | Purchase | 1,118,400 | 16 | 17,894,400 | I |
| 16 Feb 2023 17:04 | MLYS | Mineralys Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 14 Feb 2023 | Purchase | 131,600 | 16 | 2,105,600 | I |
| 16 Feb 2023 16:54 | MLYS | Mineralys Therapeutics Inc | LEVY ADAM SCOTT | CFO, Chief Bus. Off. and Secy. | 14 Feb 2023 | Purchase | 6,250 | 16 | 100,000 | D |
| 16 Feb 2023 16:54 | MLYS | Mineralys Therapeutics Inc | AKKARAJU SRINIVAS | Director , 10% | 14 Feb 2023 | Purchase | 937,500 | 16 | 15,000,000 | I |
| 16 Feb 2023 16:54 | MLYS | Mineralys Therapeutics Inc | SLINGSBY BRIAN TAYLOR | Director , 10% | 14 Feb 2023 | Purchase | 250,000 | 16 | 4,000,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)